BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8183584)

  • 1. [Thrombin-induced platelet aggregation in the presence of negatively charged liposomes].
    Zakrevskiĭ VI; Kubatiev AA
    Patol Fiziol Eksp Ter; 1994; (1):19-20. PubMed ID: 8183584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of liposome phospholipids in collagen-induced platelet aggregation].
    Zakrevskiĭ VI; Kubatiev AA; Galaev IuV
    Vopr Med Khim; 1993; 39(5):21-3. PubMed ID: 8279135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of negatively charged liposomes on thrombocyte aggregation induced by ADP].
    Zakrevskiĭ VI; Rud'ko IA; Kubatiev AA
    Biull Eksp Biol Med; 1992 Nov; 114(11):464-6. PubMed ID: 1290810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
    Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
    Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans.
    Murphey LJ; Malave HA; Petro J; Biaggioni I; Byrne DW; Vaughan DE; Luther JM; Pretorius M; Brown NJ
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1287-92. PubMed ID: 16772538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelets activity of some xanthone derivatives.
    Rajtar G; Zółkowska D; Kleinrok Z; Marona H
    Acta Pol Pharm; 1999; 56(4):319-24. PubMed ID: 10635366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of liposomes and platelets.
    Reinish LW; Bally MB; Loughrey HC; Cullis PR
    Thromb Haemost; 1988 Dec; 60(3):518-23. PubMed ID: 3238654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: identification as phosphatidylglycerol.
    Lekka M; Tokumura A; Tsuji H; Hanahan DJ
    Arch Biochem Biophys; 1993 May; 302(2):380-4. PubMed ID: 8489242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of rat platelet aggregation by Urtica dioica leaves extracts.
    El Haouari M; Bnouham M; Bendahou M; Aziz M; Ziyyat A; Legssyer A; Mekhfi H
    Phytother Res; 2006 Jul; 20(7):568-72. PubMed ID: 16619332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipids released from activated platelets improve platelet aggregation and endothelial cell migration.
    Xiao H; Siddiqui RA; Al-Hassani MH; Sliva D; Kovacs RJ
    Platelets; 2001 May; 12(3):163-70. PubMed ID: 11304418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A; Robson CA
    J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
    Nyby MD; Sasaki M; Ideguchi Y; Wynne HE; Hori MT; Berger ME; Golub MS; Brickman AS; Tuck ML
    J Pharmacol Exp Ther; 1996 Aug; 278(2):503-9. PubMed ID: 8768697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
    Maaroufi RM; Giordano P; Triadou P; Tapon-Bretaudière J; Dautzenberg MD; Fischer AM
    Thromb Res; 2007; 120(4):615-21. PubMed ID: 17222891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of thrombin-induced platelet aggregation to inhibition by ethanol.
    Marumo M; Wakabayashi I
    Clin Chim Acta; 2009 Apr; 402(1-2):156-9. PubMed ID: 19168042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release.
    Hogaboam CM; Befus AD; Wallace JL
    J Immunol; 1993 Oct; 151(7):3767-74. PubMed ID: 8397260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3,4,5-trisphosphate triggers platelet aggregation by activating Ca2+ influx.
    Lu PJ; Hsu AL; Wang DS; Chen CS
    Biochemistry; 1998 Jul; 37(27):9776-83. PubMed ID: 9657691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.